Administrators Joachim Schreef Januari26 , 2021 Administrators Share Schreef Januari26 , 2021 Multiple sclerosis (MS) is a chronic inflammatory disease that affects the central nervous system, in which nerve cells are attacked by the patient's own immune system. In many cases, the disease develops into a progressive form, which is characterized by a shift of pathology from the white matter to the gray matter, for instance, to the cerebral cortex. This phase of the disease has so far been difficult to treat and its underlying causes are poorly understood. Now, a research team led by Martin Kerschensteiner, Director of the Institute for Clinical Neuroimmunology at LMU, in cooperation with Thomas Misgeld (Technical University of Munich) and Doron Merkler (University of Geneva), has shown in a mouse model that inflammation of the gray matter leads to a decrease in nerve-cell activity, owing to the (potentially reversible) destruction of synapses. "Targeted inhibition of specific types of immune cells can slow synapse damage down, and offers an interesting new therapeutic approach," Kerschensteiner explains.Link naar het originele artikel Link to comment Share on other sites More sharing options...
Recommended Posts
Maak een account aan of login om te reageren
Je moet forum lid zijn om te kunnen reageren
Maak een account aan
Maak een account aan voor het forum. Het is niet moeilijk!
Registreer een nieuw accountLog in
Als u al een account heeft? log hier in
Log nu in